Picture of Vir Biotechnology logo

VIR — Vir Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vir Biotechnology Inc reports results for the quarter ended in June - Earnings Summary

* Vir Biotechnology Inc  VIR.OQ  reported a quarterly
adjusted
loss of $1.02​​ per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of $-1.45.  The mean expectation of eight analysts for the
quarter was for a loss of 90 cents per share. Wall Street
expected results to range from $-1.10 to -54 cents per share.
    * Revenue fell 19% to $3.08 million from a year ago;
analysts
expected $7.50 million. 
    * Vir Biotechnology Inc's reported EPS for the quarter was a
loss
of $1.02​.
    * The company reported a quarterly loss of $138.38 million.
    * Vir Biotechnology Inc shares had risen by 14.2% this
quarter and
gained 1.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Vir Biotechnology
Inc is $20.00 
This summary was machine generated from LSEG data August 1 at
09:37 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.90          -1.02          Missed
 Mar. 31 2024      -1.05          -0.48          Beat
 Dec. 31 2023      -1.01          -0.86          Beat
 Sep. 30 2023      -1.21          -1.22          Missed

Recent news on Vir Biotechnology

See all news